Serum IL-6 in NSCLC patients was increased, although not statistically significant, as compared to normal volunteers (mean ± SD: 7.94 ± 8.48 pg/mL vs. 2.71 ± 2.36, p = 0.0693; Figure 1D). The gene discussed is IL6; the disease is non-small cell lung carcinoma.